DEKA Research & Development Risk Report
Explore DEKA Research & Development across six non‑financial risk dimensions:ESG, Workforce, News & Media, Cybersecurity, Legal & Regulatory, Operational. Unlock the full report, original sources and timelines, and enable continuous monitoring.
Summary
📜 Innovation & R&D
DEKA Research & Development demonstrates significant activity in innovation and R&D. Their advancements in medical technology, particularly in prosthetics and insulin delivery systems, signify their commitment to healthcare innovation. These developments not only enhance patient quality of life but also strengthen the company's competitive position in the market.
- DEKA's new erectile dysfunction technology, the PelviTouch, emerged from Italian technology 🗓 2025-02-21.
- The Trump Administration planned to showcase DEKA's point-of-care technology for IV fluid shortages 🗓 2025-06-06.
- DEKA's automated insulin delivery system received FDA clearance 🗓 2024-03-20.
- DEKA's collaboration on the Tidepool-powered insulin pump and its FDA clearance were a major innovation step 🗓 2024-03-18.
- Their LUKE/DEKA prosthetic arm was recognized by U.S. Veterans Affairs for its innovation in prosthetics 🗓 2024-05-09.
🏗️ Operational & Business Continuity
DEKA maintains operational stability through strategic collaborations and expanding technologies. These ventures support the company's operations despite the inherent risks involved in pioneering new technologies.
- DEKA's collaboration with Zealand Pharma highlights strategic alliances in operation 🗓 2021-11-05.
- DEKA entered an R&D collaboration with Emergent 😅 🗓 2024-01-16.
⚖️ Legal & Regulatory
DEKA operates in a heavily regulated industry but appears proactive in legal compliance, as indicated by multiple clearances from the FDA. This reflects a sound approach to regulatory adherence, which is crucial for its continued operation and reputation.
- DEKA's automated insulin system received 510(k) clearance from the FDA, underscoring regulatory compliance 🗓 2024-03-19.
🏅 Awards & Recognition
DEKA received notable recognition for its contributions to medical technology and innovation. While specific awards are not detailed, such acknowledgments underscore the company's leading role in its industry sector.
- The DEKA-designed automated insulin pump gained attention for its impact on Type 1 Diabetes management 🗓 2024-03-18.
Profile
News & Media
Real‑time aggregation of trusted sources tracking company‑related events with sentiment and topic tags for rapid risk triage.
Sign up to unlock DEKA Research & Development’s complete news feed with sentiment and topic tags.
View Full ReportEntity List
Continuous third‑party screening across global sanctions, enforcement, and watchlist sources with unified entity resolution and real‑time alerts.
| Name | Issuer | Status |
|---|---|---|
| ACF List of War Enablers | Anti-Corruption Foundation | |
| African Development Bank Debarred Entities | African Development Bank Group | |
| Argentina Members of Parliament | Honorable Cámara de Diputados de la Nación Argentina | |
| Argentina RePET Sanctions | Ministerio de Justicia | |
| Armenia Public Officials and Associates | Hetq Online | |
| Asian Development Bank Sanctions | Asian Development Bank | |
| Australian Sanctions Consolidated List | Department of Foreign Affairs and Trade | |
| Democratic People's Republic Of Korea (North Korea) Sanctions Regime | Department of Foreign Affairs and Trade | |
| Former Federal Republic Of Yugoslavia Sanctions Regime | Department of Foreign Affairs and Trade | |
| Iran Sanctions Regime | Department of Foreign Affairs and Trade |
Sign up to unlock DEKA Research & Development’s sanctions, enforcement, and watchlist risk profile.
View Full ReportESG
Verification of declared ESG commitments and certifications with evidence links, score signals, and status updates across E, S, and G.
| Name | Status |
|---|---|
| Sustainable Finance Disclosure Regulation | |
| Global Reporting Initiative Standards | |
| EU Taxonomy Regulation | |
| EU Corporate Sustainability Reporting Directive | |
| California Transparency in Supply Chains Act | |
| EU Non-Financial Reporting Directive | |
| ISO 14001 | |
| Sustainability Accounting Standards Board Standards | |
| Task Force on Climate-related Financial Disclosures | |
| UN Guiding Principles on Business and Human Rights |
Sign up to unlock DEKA Research & Development’s ESG commitments, certifications, and controversy signals.
View Full ReportCybersecurity
Verification of adherence to recognized security standards, mapping control coverage and gaps affecting third‑party and supply‑chain risk.
| Certification | Status |
|---|---|
| General Data Protection Regulation | |
| Digital Operational Resilience Act | |
| Cybersecurity Maturity Model Certification | |
| NIST Cybersecurity Framework | |
| NIST 800-53 Revision 5 | |
| California Consumer Privacy Act | |
| ISO/IEC 27001 | |
| Health Insurance Portability and Accountability Act | |
| Payment Card Industry Data Security Standard | |
| Federal Information Security Modernization Act |
Sign up to unlock DEKA Research & Development’s security standards, control gaps, and exposure risks.
View Full ReportGet DEKA Research & Development's full Non-Financial Risk Report
By signing up, you agree to our Terms and Privacy Policy.